China detains five AstraZeneca staff in investigation over ‘data privacy and import breaches’

Detentions of current and former workers involve Chinese citizens who marketed cancer drugs for firm’s oncology division

Chinese police have reportedly detained five current and former AstraZeneca employees as part of an investigation into possible breaches related to data privacy and importing unlicensed medications.

The detentions took place earlier this summer, and targeted Chinese citizens who marketed cancer drugs for the oncology division of the British pharmaceutical company, according to Bloomberg.